Masimo Corp. (NASDAQ:MASI) is scheduled to release its Q114 earnings data on Wednesday, April 30th. Analysts expect Masimo Corp. to post earnings of $0.29 per share and revenue of $144.01 million for the quarter. Masimo Corp. has set its FY14 guidance at $1.13 and $1.28 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.
Masimo Corp. (NASDAQ:MASI) last announced its earnings results on Thursday, February 13th. The company reported $0.31 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.31. The company had revenue of $134.70 million for the quarter, compared to the consensus estimate of $148.25 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, analysts expect Masimo Corp. to post $1.15 EPS for the current fiscal year and $1.32 EPS for the next fiscal year.
Shares of Masimo Corp. (NASDAQ:MASI) opened at 26.31 on Tuesday. Masimo Corp. has a 1-year low of $19.57 and a 1-year high of $32.20. The stock has a 50-day moving average of $27.2 and a 200-day moving average of $28.14. The company has a market cap of $1.492 billion and a P/E ratio of 25.54.
On a related note, analysts at Zacks reiterated a “neutral” rating on shares of Masimo Corp. in a research note on Tuesday, February 18th. They now have a $29.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $27.80.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.